收稿日期: 2021-11-08
修回日期: 2022-01-25
网络出版日期: 2022-07-06
基金资助
新疆维吾尔自治区重点实验室开放课题(2019D04021);新疆维吾尔自治区天山青年计划“杰出青年科技人才”项目(2020Q007);国家自然科学基金(81860359);国家自然科学基金(82160397);省部共建中亚高发病成因与防治国家重点实验室开放课题项目(SKL-HIDCA-2020-5)
Analysis of the influencing factors of lesion activity in hepatic cystic echinococcosis patients
Received date: 2021-11-08
Revised date: 2022-01-25
Online published: 2022-07-06
Supported by
Open Project of Key Laboratory of Xinjiang Uygur Autonomous Region(2019D04021);“Outstanding Young Scientific and Technological Talents” Project of Tianshan Youth Program in Xinjiang Uygur Autonomous Region(2020Q007);Natural Science Foundation of China(81860359);Natural Science Foundation of China(82160397);Open Project of State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia(SKL-HIDCA-2020-5)
目的 明确影响肝细粒棘球蚴病患者病灶活性状态的主要因素,为提高细粒棘球蚴病的诊疗效果提供决策依据。 方法 收集2018年1月至2020年6月在新疆医科大学第一附属医院行手术治疗的251例肝细粒棘球蚴病患者的人口学信息和临床相关资料,应用影像学技术,并结合其生物学特性将病灶CE1、CE2、CE3分为活性组,病灶CE4、CE5分为无活性组,以病灶有无活性为因变量进行单因素分析,根据单因素分析结果,构建非条件logistic回归模型,分析影响病灶活性状态的独立影响因素。使用SPSS 26.0统计软件进行统计学分析。 结果 本研究符合纳入标准的251例肝细粒棘球蚴病手术患者中,女性占57.0%(143例),高于男性的43.0%(108例);年龄为4~85岁,平均年龄为(41.31 ± 15.05)岁;患者文化程度偏低,高中及以下文化程度占79.3%(199例);居住乡村占比为66.9%(168例),高于居住城市的33.1%(83例);汉族占42.2%(106例),其他少数民族占57.8%(145例);初发占比为78.1%(196例),高于复发的21.9%(55例);有活性病灶占比为76.9%(193例),高于无活性病灶的23.1%(58例)。单因素分析结果显示,不同年龄、民族、有无复发、病灶数、病灶大小以及血液检查指标红细胞、凝血酶原时间、直接胆红素和碱性磷酸酶与肝细粒棘球蚴病患者的病灶活性状态差异有统计学意义(χ2 = 17.110、7.797、2.906、4.702、16.520,Z = -1.989、2.446、2.003、1.914;P < 0.1)。非条件logistic回归结果显示,影响肝细粒棘球蚴病患者病灶活性状态的主要因素为年龄和病灶大小, 年龄越小、病灶越大其病灶活性占比越高(P < 0.05)。 结论 通过对251例肝细粒棘球蚴病手术患者的临床资料分析显示,年龄越小和病灶越大是影响肝细粒棘球蚴病患者病灶活性状态的独立影响因素。
侯娇 , 温浩 , 王明坤 , 蒋铁民 , 房彬彬 , 李静 , 张传山 , 王慧 . 肝细粒棘球蚴病手术患者病灶活性状态的影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2022 , 40(3) : 309 -314 . DOI: 10.12140/j.issn.1000-7423.2022.03.005
Objective To identify the main factors affecting the active state of lesions in patients with hepatic cystic echinococcosis and provide the basis for decision-making to improve the diagnosis and treatment of cystic echinococcosis. Methods A total of 251 patients with hepatic cystic echinococcosis receiving surgical treatment at the First Affiliated Hospital of Xinjiang Medical University from between January 2018 and June 2020 were enrolled, and their demographic information and clinical data were collected, Based on the imaging and biological characteristics, the cysts classified as CE1, CE2 and CE3 were grouped as active group, and CE4 and CE5 inactive group. Using the cyst activity as the dependent variable, univariate analysis was performed, based on which unconditinal logistic regression model was constructed to analyze the independent factors influencing the cyst activity status. Results In this study, clinical data of 251 patients with hepatic cystic echinococcosis meeting the inclusion criteria were collected, with 57.0% (143 cases) female and 43.0% (108 cases) male. The age of the patients ranged from 4 to 85 years old, and the average age was (41.31 ± 15.05) years old. Most of the patients had a low educational level, with high school or below accounting for 79.3% (199 cases); the rural resident accounted for 66.9% (168 cases), which is higher than that of the urban resident 33.1% (83 cases). The percentage of CE in Han nationality was 42.2% (106 cases), while that in other minority nationalities was 57.8% (145 cases). The percentage of patients with their first infection was 78.1% (196 cases), which is higher than that of the recurrent infection (21.9%, 55 cases). The active lesions accounted for 76.9% (193 cases), and the inactive lesions accounted for 23.1% (58 cases). The results of the univariate analysis showed that there were significant differences among patients with different age groups, ethnic groups, the active state of lesions between patients with hepatic cystic echinococcosis and those without recurrence, the number of lesions, the size of lesions, red blood cell count, prothrombin time, direct bilirubin and alkaline phosphatase (χ2 = 17.110, 7.797, 2.906, 4.702, 16.520, Z = -1.989, 2.446, 2.003, 1.914, P < 0.1). Unconditional Logistic regression results showed that the main factors affecting the active status of lesions in patients with hepatic cystic echinococcosis were age and lesion size. Larger lesions tend to occur in younger patients(P < 0.05). Conclusion The analysis on the clinical data of 251 hepatic cystic echinococcosis patients receiving surgical treatment demonstrated that younger age and larger cyst size were the independent factors affecting the activity status of cysts.
| [1] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-18. |
| [2] | Tuerhongjiang T, Shao YM, Tuerganaili A, et al. Consensus on chinese terminology in the clinical field of echinococcosis[J]. Chin J Parasitol Parasit Dis, 2021, 39(1): 76-84. (in Chinese) |
| ( 吐尔洪江·吐逊, 邵英梅, 吐尔干艾力·阿吉, 等. 棘球蚴病临床领域相关中文专业术语专家共识[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(1): 76-84.) | |
| [3] | Zhu YY, Wu WP. Advances in echinococcosis prevention and control programs and research in China and elsewhere around the world[J]. J Pathog Biol, 2016, 11(3): 284-286, 289. (in Chinese) |
| ( 朱曜宇, 伍卫平. 国内外包虫病防治和研究进展[J]. 中国病原生物学杂志, 2016, 11(3): 284-286, 289.) | |
| [4] | Xu CX, Kong XL. Current situation of epidemic and control of echinococcosis[J]. Chin J Tradit Vet Sci, 2015(9): 67. (in Chinese) |
| ( 许春晓, 孔席丽. 包虫病的流行及防治现状[J]. 中国兽医学杂志, 2015(9): 67.) | |
| [5] | Sun L, Fang BB, Wang J, et al. Current status of drug treatment and construction of medical cooperation system for echinococcosis patients in Jimusar County, Changji Prefecture, Xinjiang[J]. Chin J Endemiol, 2020, 39(2): 128-134. (in Chinese) |
| ( 孙立, 房彬彬, 王军, 等. 新疆维吾尔自治区昌吉州吉木萨尔县包虫病患者药物治疗现状及医防结合体系建设[J]. 中华地方病学杂志, 2020, 39(2): 128-134.) | |
| [6] | Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic echinococcosis[J]. J Clin Microbiol, 2016, 54(3): 518-523. |
| [7] | Zhang MY, Wu WP, Guan YY, et al. Analysis on disease burden of hydatid disease in China[J]. Chin J Parasitol Parasit Dis, 2018, 36(1): 15-19, 25. (in Chinese) |
| ( 张梦媛, 伍卫平, 官亚宜, 等. 我国棘球蚴病疾病负担分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1): 15-19, 25.) | |
| [8] | Wen H, Tuerganaili A, Shao YM, et al. Research achievements and challenges for echinococcosis control[J]. Chin J Parasitol Parasit Dis, 2015, 33(6): 466-471. (in Chinese) |
| ( 温浩, 吐尔干艾力·阿吉, 邵英梅, 等. 棘球蚴病防治成就及面临的挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 466-471.) | |
| [9] | Chen ZY. Prevention and treatment of echinococcosis[J]. Chin J Bases Clin Gen Surg, 2020, 27(1): 1-3. (in Chinese) |
| ( 陈哲宇. 包虫病的防治[J]. 中国普外基础与临床杂志, 2020, 27(1): 1-3.) | |
| [10] | Chinese Doctor Association, Chinese College of Surgeons (CCS). Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. (in Chinese) |
| 中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721.) | |
| [11] | WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans[J]. Bull World Health Organ, 1996, 74(3): 231-242. |
| [12] | WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings[J]. Acta Trop, 2003, 85(2): 253-261. |
| [13] | Li T, Bao HH. Evaluation of computer tomography and magnetic resonance imaging in the classification and viability of hepatic cystic echinococcosis[J]. Chin J Magn Reson Imaging, 2021, 12(5): 25-29. (in Chinese) |
| ( 李婷, 鲍海华. CT和MRI对肝囊型包虫病分型与活性的评价[J]. 磁共振成像, 2021, 12(5): 25-29.) | |
| [14] | Wen H, Luan MX, Yang WG, et al. Study on standard classification and clinical significance for hepatic echinococcosis[J]. J Xinjiang Med Univ, 2002, 25(2): 129-130. (in Chinese) |
| ( 温浩, 栾梅香, 杨文光, 等. 肝包虫病的标准化分型及临床意义探讨[J]. 新疆医科大学学报, 2002, 25(2): 129-130.) | |
| [15] | Baheti K, Meng Y, Chen LJ, et al. Risk factors of biliary fistula in patients with cystic echinococcosis[J]. Chin J Hepatic Surg Electron Ed, 2020, 9(3): 244-248. (in Chinese) |
| ( 巴合提·卡力甫, 孟塬, 陈伦牮, 等. 肝囊型包虫病胆瘘发生影响因素分析[J]. 中华肝脏外科手术学电子杂志, 2020, 9(3): 244-248.) | |
| [16] | Zhang J, Qi BW, Song W, et al. Clinical features, diagnosis and treatment and prognosis of patients with hepatic echinococcosis in Xinjiang: a 10-year single-center retrospective study[J]. Chin Gen Pract, 2020, 23(36): 4573-4577. (in Chinese) |
| ( 张杰, 齐宝文, 宋巍, 等. 新疆地区肝包虫病患者临床特征和诊疗模式及预后的十年回顾性分析: 一项单中心研究[J]. 中国全科医学, 2020, 23(36): 4573-4577.) | |
| [17] | Zhu LH, Zhu LM, Wang B, et al. Analysis of clinical features of echinococcosis cases[J]. Chin J Parasitol Parasit Dis, 2021, 39(1): 61-68. (in Chinese) |
| ( 朱凌虹, 祝路民, 王勃, 等. 棘球蚴病住院患者临床特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(1): 61-68.) | |
| [18] | Manterola C, Urrutia S, Group MINCRR. Infected hepatic echinococcosis: results of surgical treatment of a consecutive series of patients[J]. Surg Infect (Larchmt), 2015, 16(5): 553-557. |
| [19] | Tang QK, Zhang Y, Li YS, et al. The diagnosis and treatment of recurrent hepatic hydatld[J]. J Hepatobiliary Surg, 2004, 12(6): 428-430. (in Chinese) |
| ( 唐群科, 张瑛, 李永寿, 等. 复发性肝包虫病的诊治[J]. 肝胆外科杂志, 2004, 12(6): 428-430.) | |
| [20] | Wang ZX, Li Y, Wang JY, et al. Hepatic alveolar echinococcosis recurring after autologous liver transplantation: a case report[J]. J Clin Hepatol, 2020, 36(8): 1832-1834. (in Chinese) |
| ( 王志鑫, 李姚, 王江瑜, 等. 肝泡型包虫病自体肝移植术后复发1例报告[J]. 临床肝胆病杂志, 2020, 36(8): 1832-1834.) |
/
| 〈 |
|
〉 |